top of page
WellSIM Biomedical Technologies is a life-science technology company supported by Illumina Accelerator. The company specializes in state-of-the-art extracellular vesicle analysis technology, designed for both research and clinical applications.

We are currently offering early access custom services for high-speed and high-sensitivity EV surface marker analysis utilizing our ExoDot technology. Our goal is to develop a fully integrated and automatic system based on this technology. We are developing
 this platform for cost-effective, highly accurate diagnosis of Alzheimer's disease.

Extracellular vesicles are small lipid bilayer particles that contain a variety of biomolecules, including lipids, proteins, and nucleic acids. They are produced by most cell types and can be found in almost all bodily fluids. EVs play a crucial role in cellular communication and signaling, with significant physiological and pathological implications. By examining EV-derived biomarkers, such as DNA, RNA, protein, and lipid profiles, it is possible to detect and diagnose a range of diseases, including cancers, neurodegenerative and autoimmune diseases. Additionally, EVs are emerging as an innovative therapeutic platform, capable of delivering therapeutic materials directly to target tissues and cells.
bottom of page